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ABSTRACT 
 
The cleft palate and lip is one of the most common birth defects that may or may not be 
syndromic. Clefting may manifest unilaterally or bilaterally with varying degrees of severity. In 
embryo, the upper and lower jaws were formed from the first brachial arches that descend from 
both sides and fuse. Many genetic loci and cell-signaling pathways have been identified with the 
fusion event, in which polar neural crest cells undergo the epithelial-to-mesenchymal transition. 
Genetic mutations, environmental teratogens, and nutrition have been associated with the cleft 
palate and lip. The extracellular matrix has been extensively studied to understand cell-cell 
communication and is crucial in tissue engineering. The gold standard today for palatal 
reconstruction remains to be an autogenous graft from the anterior iliac crest. Autogenous bone 
grafts have many disadvantages such as donor site morbidity. New approaches in tissue 
engineering involving stems cells, growth factors, and biomaterial scaffolding have been 
identified to avoid autogenous bone grafts. Mesenchymal cells may be harvested from dental 
tissue and adipocytes. Three-dimensional printing and computer-aided design are becoming 
widely used in oral surgery. More research are underway to overcome the challenges in soft 
tissue reconstruction of the soft palate.  
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Dentists are medical practitioners who specialize in the oral cavity, including teeth, gum, 
and in some cases, the tongue, the mucosa lining in the oral cavity, and the maxilla and mandible 
bones of the jaw. Aside from general dentistry, the American Dental Association recognizes nine 
specialties in dentistry, including dental anesthesiology, dental public health, endodontists, oral 
and maxillofacial pathology, oral and maxillofacial radiology, oral and maxillofacial surgery, 
orthodontics and dentofacial orthopedics, pediatric dentistry, periodontics, and prosthodontics 
(National Commission and Recognition of Dental Specialties and Certifying Boards). In many 
cases, multiple specialists are required to work alongside the general dentist to treat one patient. 
In the case of orofacial clefting, a multidisciplinary team of surgeons, anesthesiologists, dentists, 
and orthodontists are usually required for a better outcome and quality of life (Paiva et al., 2019). 
Orofacial clefting compromises the integrity of the craniofacial complex, which then affects 
fundamental functions such as speech, mastication, deglutition, and aesthetics (Zhang et al., 
2018). Depending on the severity, clefting often results in gaps in the alveolar bone, traditionally 
treated using osteoplasty via an autogenic bone graft (Vuletić et al., 2014). If the patient presents 
missing teeth, implants and orthodontic treatment are widely utilized. Although an autologous 
bone graft is currently considered the gold standard in osteoplasty, it still presents disadvantages 
that may be overcome using growth factor-aided tissue engineering and other regenerative 
methods of treatment (Vuletić et al., 2014).  
Orofacial clefting is one of the most common forms of birth defects. Three main 
categories emerge from all clefting cases: isolated cleft lip and/or alveolus; isolated cleft palate; 
and combined cleft lip, alveolus, and palate. Each category is subdivided based on the severity of 
the cleft as complete or incomplete, and unilateral or bilateral based on the number of clefts 
(Meng et al., 2009). Cleft lip with or without cleft palate (CLP) (Figure 1 a through d) is more 
common than isolated cleft palate without cleft lip (CPO) (Figure 1 e). Limited research has been 
done to identify how CPO differs from CLP in terms of etiology, genetic associations, and risk 
factors, because CPO is often excluded from studies or combined with cases of CLP (Burg et al., 
2016). For CLP, North American Indians and Asians have the highest prevalence rates of 1 in 
500 live births; Caucasian populations are observed to have intermediate rates of 1 in 1000 live 
births; populations from the African descent have the lowest rates of CLP prevalence of 
approximately 1 in 2500 live births. Japanese populations are found to have the highest rate of 
CLP occurrence (1 in 500 live births) among all Asian populations (Murthy et al., 2009; Omiya 
et al., 2014). Biological sex contributes significantly to CLP frequency, as it exhibits a 2:1 male 
to female ratio. For unilateral clefts, the left side is more prevalent with a 2:1 left side to right 
side ratio (Murthy et al., 2009). Isolated cleft palate without cleft lip (CPO) is the rarest form of 
oral clefting and is more common in females than males (Burg et al., 2016). Approximately 30% 
of orofacial clefts are syndromic and occur with the presence of other developmental 
abnormalities. Over 300 syndromes have been identified to associate with different forms of 
CLP. The remaining 70% of CLP cases are considered isolated or non-syndromic (Meng et al., 
2009). Conditions involving orofacial clefting are relatively common and can result in a drastic 
decreased quality of life if not treated with surgical intervention and orthodontics. Research has 
revealed many possible causes for the cleft palate, including genetic and environmental factors. 
Teratogens, genetic abnormalities, and alterations in the extracellular matrix have been shown to 
strongly associate with newborns with orofacial clefting (Meng et al., 2009).  
 
Figure 1. Types of orofacial clefting involving the palate. (a) Unilateral cleft lip with alveolar 
involvement; (b) bilateral cleft lip with alveolar involvement; (c) unilateral cleft lip associated 
with cleft palate; (d) bilateral cleft lip and palate; (e) cleft palate only; (a) through (d) represent 
different types of cleft lip with or without cleft palate (CLP); (e) is seen in isolated cleft palate 
without cleft lip (Brito et al., 2012). 
 
Normal development and genetic involvement 
The human palate is divided into a bony hard palate and a fibromuscular soft palate. The 
hard palate lies anterior to the soft plate. The incisive foramen is the anatomical marker that 
divides the hard palate into the primary and secondary palate. The primary palate is anterior to 
the incisive foramen and contains the maxillary incisors. The secondary palate is posterior to the 
incisive foramen and separates the nasal passage from the pharynx (Burg et al., 2016; Jankowski 
et al., 2016). The palate develops between the 4th and the 12th to 13th weeks after conception in 
the human embryo (Warren et al., 2012). This process begins with five pairs of bilaterally 
symmetric protrusions, called branchial or pharyngeal arches that approach the midline on the 
ventral side of the embryo. The frontonasal prominences descend to form the external nose and 
the intermaxillary segment that contributes to the primary palate between the 5th to the 7th weeks 
of gestation. The prominences are derived from two ectoderm nasal or olfactory placodes as they 
enlarge and separates into the nasomedial and nasolateral processes. The nasomedial process 
descends and merges with the intermaxillary process (Graham, 2003; Jankowski et al., 2016). 
The first pair of branchial arches develops into the maxillary and mandibular processes, 
precursors of the upper and lower jaws, respectively. The maxillary processes fuse with the 
frontonasal prominences after the formation of the nose and the intermaxillary segment. In early 
facial development, cells involved may trace their lineage back to mesenchymal cells that are 
derived from the mesoderm encased in epithelial cells that either derived externally from the 
ectoderm or internally from the endoderm, depending on their physical location. However, 
neural crest cells are considered one of the largest contributors to facial development. 
 
Figure 2. Scanning electron micrograph of Carnegie stage 14. Four pharyngeal arches are shown 
in green, tan, blue, and purple. One pharyngeal arch is not externally visible. The first pharyngeal 
arch develops into the maxillary and mandibular processes. Each arch consists of an internal 
endodermal pouch, a mesenchymal core (formed from the mesoderm and the neural crest cells), 
a membrane (from endoderm and ectoderm) and an external cleft (from ectoderm) (Hill, 2020). 
In humans, the first pharyngeal arch (green) differentiates into structures along the side of the 
face and the lower jaw, such as the Meckel’s cartilage, the sphenomandibular ligament, and the 
malleus and the incus in the middle ear; the second pharyngeal arch (tan) differentiates into 
inferior structures such as the stapes in the middle ear, the styloid process, the stylohyoid 
ligament, and the lesser horn of hyoid bone; the third arch (blue) contributes to the greater horn 
of hyoid bone; the fourth arch (purple) gives rise to the thyroid and cricoid cartilage (Carlson, 
2008).   
Neural crest cells are highly proliferating and migratory in nature (Graham, 2003). 
Concurrent with the closure of the neural tube, the crest of the neural folds gives rise to the 
neural crest cells. In the beginning, neural crest cells appear as classic, tightly-bound epithelial 
cells with distinct apical-basal polarity. As shown in animal studies, the neural tube cells begin 
their metamorphic journey upon or before the closure of the neural tube in chick and mice 
embryos, respectively. The tight and adherens junctions and desmosomes start to disintegrate, 
and changes are observed in the cytoskeleton (Savagner, 2001). This marks the transition the 
neural crest cells undergo to adopt more mesenchymal properties, a process called an 
embryological epithelial-to-mesenchymal transition (eEMT). The mesenchyme is a special type 
of embryonic connective tissue with various destinations after differentiation. With more 
mesenchymal properties, the mesenchymal cells become known as ectomesenchyme. The eEMT 
transition allows the neural crest cells to better migrate laterally to the ventral side of the embryo. 
The ectomesenchyme will ultimately differentiate into the connective tissue skeletal structures of 
the face and determine facial appearance (Schneider et al., 2003). The outgrowth process is 
defined by the proliferation and differentiation of the neural crest cells. Many factors have been 
shown to affect the growth patterns of cranial neural crest cells, but they all contain a set of 
intrinsic and unchanging set of pattern of outgrowth that may not be overridden (Cox, 2004). 
These neural crest cells receive signals from multiple epithelial tissues, as demonstrated in 
microsurgical transplantation experiments with the pharyngeal endoderm (Couly et al., 2002) 
and frontonasal ectoderm (Hu et al., 2003). Secreted signals from the fibroblast growth factor 
(FGF), bone morphogenetic protein (BMP) families, sonic hedgehog (SHH), and components of 
the endothelial signaling pathway have been shown to influence the outgrowth of the frontonasal 
and maxillary processes (Clouthier et al., 2000; Richman et al., 2003). 
 Because the cranial facial tissue is derived from multiple cell lines with different growth 
rates, the interaction between the epithelial and mesenchymal cells is deemed to be crucial in 
development. The differences in growth rate manifests as the maxillary and mandibular 
prominences rapidly proliferate and consolidate while the frontonasal prominence divides in a 
comparatively consistent rate. Different types of facial dysmorphology arise depending on the 
severity, timing, and the type of cells affected by genetic and/or environmental influences. 
Perturbations may act directly on neural crest cells or act upon the signaling pathway between 
the neural crest cells and their neighboring ectodermal, endodermal, mesodermal epithelium, and 
mesenchyme (Cox, 2004). For example, Tbx1 knockout mice exhibit disrupted signaling from 
the pharyngeal arch endoderm and mesoderm and the differentiation processes of neural crest 
cells in the arches. Facial and cardiovascular abnormalities were found in Tbx1 haploinsufficent 
mice, consistent with clinical observations with patients with DiGeorge syndrome, a relatively 
common form of birth defect affecting craniofacial development (Baldini, 2002). DiGeorge 
syndrome displays in a board spectrum of clinical manifestations, with approximately 70% of 
cases presenting one form of abnormality of the palate. In one study, submucous cleft palate was 
found to be the most prevalent in Chilean patients, constituting approximately 20% of all cases 
of newborns with DiGeorge syndrome (Rozas et al., 2019).  
 Before the medial nasal and the maxillary processes fuse, scattered apoptosis must occur 
in order to allow the fusion of the primary and the secondary palates (Sun et al., 2000; Holtgrave 
et al., 2002). This apoptosis process serves several functions. Take the fusion of the primary 
palate as an example, dying cells make room in the pre-contact area for the eventual merger of 
the medial nasal and the maxillary processes. These dying cells protrude and weaken the cell-to-
cell contact in the epithelia and allow the region to bulge out. The initial contact, recognition, 
and consolidation is facilitated by filopodia induced on the epithelial surface before the eEMT 
process begins within the epithelial cells at the fusion site (Figure 3) (Cox, 2004).  
 
Figure 3. The seven stages of primary palate fusion. The increased expression of BMP4 during 
stage 1 allows the epithelial cells at the pre-fusion contact zone to undergo a cascade of cellular 
changes including apoptosis (stage 2), apical surface bulging (stage 3), and filopodia formation 
(stage 4). Adherent junctions, right junctions, and desmosomes (stage 5) are formed at contact 
site, followed by the epithelial-to-mesenchymal transition (EMT) and the breakdown of basal 
lamina. When EMT is complete, the primary palate should consist of confluent mesenchymal 
cells (Cox, 2004).  
 
Apoptosis is crucial for all of the subsequent steps in the epithelial seam formation, 
which is why the mice model deficient in Apaf1, a gene coding for an apoptotic factor, reveal 
phenotypes including midline facial cleft and cleft palate (Cecconi et al., 1998). Following 
induced apoptosis, the remaining epithelial cells adopt cell boundaries that are less defined at the 
medial edge epithelia (MEE) (Souchon, 1975; Martínez-Alvarez et al., 2000). As primary palate 
develops in mice, the epithelial cells in the maxillary, medial nasal and lateral nasal processes 
express BMP4, a member of the transforming growth factor- (TGF-) superfamily. The 
expression of this gene becomes restricted to the region of pre-fusion contact region and persists 
as the epithelia adheres to each other and form the epithelial seam (Ashique et al., 2002; Gong et 
al., 2003). Members of the TGF- superfamily, including BMP4 and TGF-3 induce apoptosis 
in embryonic tissue and are considered to play a crucial role in development in general. BMP 
signaling activates downstream loci such as the homeobox transcription factors, MSX1 and 
MSX2. Deficiency of MSX 1 in human is found to lead to a syndromic form of CLP while 
common polymorphisms within the MSX1 locus may cause non-syndromic forms of CLP (Lidral 
et al., 1998; Ashique et al., 2002). It is suggested that the epithelial cells respond to the genetic 
signals randomly, allowing an adequate number of cells to die to make room for the merging 
processes. At the same time, enough cells must survive to make the epithelial-mesenchymal 
transition (Cox, 2004). An antagonist to TGF-3, called NOGGIN (NOG) is rapidly 
downregulated in the epithelial cells of the medial nasal where fusion contact occurs (Sela-
Donenfeld et al., 1999). In the maxillary pre-fusion contact sites, SHH is found to be 
downregulated. SHH has been demonstrated to serve different functions in the cell cycle across 
different contexts. In the context of palatogenesis, it is known as an antagonist to BMPs, thus it 
must decrease in order for the epithelial cells to become preceptive to cell death signals from 
BMPs. Its role to control the adhesive properties of the cell membrane is also proposed (Ashique 
et al., 2002; Cox, 2004). 
 The epithelial-mesenchymal transition is crucial for normal palatogenesis because the 
epithelial seam initially formed during the fusion of the processes (medial nasal, maxillary, and 
lateral nasal) from each side is not strong enough to hold the two sides together through the 
subsequent developmental events. The development of the face imposes enough torsional force 
on the seam to separate the facial prominences. In order to gain more tensile strength, the 
epithelial cells must differentiate into a confluent, thickened mesenchymal cell layer (Diewert et 
al., 1992). The merging process involves an initial contact of the opposing epithelial cells as well 
as the formation of a bilayer epithelial seam. Nectin1, a product of the PVRL1 gene, produce 
Nectins, a type of immunoglobulin-type cell-cell adhesion molecule. Nectin1 is found to be 
upregulated in facial ectoderm, palatal epithelia, and neural tissue as it introduces adherent 
junctions in the contact site with the help from E-cadherins (Takai et al., 2003). The three protein 
isoforms encoded by PVRL1 also help with forming cellular projections such as filopodia on the 
basal surface on the epithelial cells during the break down of the basal lamina during the EMT 
process. The Nectin1 ectodomains will eventually be cleaved by members of the ADAM (a 
distintegrin and metalloproteinase) family, an important player in the extracellular matrix 
transformation during palatogenesis (Kim et al., 2002; Tanaka et al., 2002; Cox, 2004).  
 The human palate is divided into the hard and the soft palate, with the hard palate further 
divided into the primary and secondary palate. The fusion of the palate occurs as the five pairs of 
pharyngeal arches approach the midline, recognize each other, and merge into one. Important 
cellular changes must occur to adapt to their new life as a consolidated unity. Appropriate 
apoptosis, changes in cell shape, development of filopodia, and the epithelial-to-mesenchymal 
transition (EMT) are considered some of the most crucial transitions. In the end, the epithelial 
seam where the palate came together should consist of a thick layer of confluent mesenchymal 
cells. Many genes have been found to be involved in this process, such as the fibroblast growth 
factor (FGF), bone morphogenetic protein (BMP) families, sonic hedgehog (SHH), Tbx1 gene, 
homeobox transcription factors (MSX1, MSX2), NOGGIN (NOG), Nectin1 (PVRL1 gene). In 
addition, extracellular changes will also occur to accommodate at the contacting surface and will 
be covered in the subsequent sections. These changes are crucial for both normal embryonic 
development and research in bioengineering for novel, regenerative approaches to correct the 
cleft palate.  
 
Environmental factors and cell stress 
 Cleft lip and palate may occur due to environmental factors such as suboptimal nutrition 
and exposure to teratogens. Many nutrient deficiencies and excesses have been found to be 
associated to CLP. Deficiencies in cholesterol, thiamin, riboflavin, niacin, pyridoxine, folate, 
cobalamin, ascorbic acid, zinc, magnesium, and myo-inositol are known to increase the risk of 
CLP. Vitamin A and iron are associated with the increased risk of CLP when either deficient or 
in excess. Excess glucose was associated with CLP instances (Krapels et al., 2006). Although the 
underlying mechanism of how these nutrients affect palatogenesis is largely unknown, many 
possible pathways have been suggested. The homocysteine pathway could be interrupted when 
involving riboflavin, folate, pyridoxine, cobalamin, and zinc as cofactors and/or substrate. The 
oxidative pathway has been shown to affect palatogenesis (Krapels et al., 2006). Oxidation states 
of enzymes, substrates, and cofactors are crucial to cell signaling, function, and gene expression. 
Glucose and homocysteine are oxidants, and ascorbic acid and glutathione are antioxidants, all of 
which would interfere with the oxidative pathway. Iron, cobalamin, and folate are involved in the 
hematopoiesis pathway, another possible candidate for causing defects during palatogenesis. 
Gene expression may be altered during the developmental process through epigenetic events 
associated with niacin and folate and/or through changing the genomic stability when involving 
magnesium, folate, and zinc. These genetic changes affect transcription and translation, thereby 
altering biochemical pathways and hormone production (Krapels et al., 2006). 
 Among all nutrients associated to orofacial clefting, vitamin A is one of the most studied 
compounds in palatogenesis. Retinoic acid (RA) is a vitamin A derivative and has many 
functions in gene regulation. Retinoic acid receptors (RAR) and retinoic X receptor (RXR) are 
nuclear receptors that are known to form dimers with each other as well as other nuclear 
receptors to regulate cell proliferation, differentiation and apoptosis (Zhang et al., 1992; Forman 
et al., 1995). High doses of RA inhibits the expression of sonic hedgehog (Shh) by eliminating 
polarizability and growth of the frontonasal and maxillary processes (Helms et al., 1997). In 
normal development, medial edge epithelial (MEE) cells do not undergo apoptosis until the 
palatal shelfs are in the horizontal position. However, when an exogenous level of RA was 
introduced in embryonic mice, the MEE cells were observed to slough off from the periderm, 
preventing further differentiation and closure of the palatal shelves. High levels of RA also 
induced apoptosis in the tongue, thus preventing it from playing its normal role in elevating the 
palate horizontally through the movement of the hyoglossus muscle (Tsunekawa et al., 2005; 
Okano et al., 2007).  
 Environmental toxins, such as 2,3,7,8-tetrachlorodibenzo-p-doxin (TCDD), a by-product 
in paper manufacturing, metal smelting and waste incineration, was found to cause cleft palate in 
mice (Wang et al., 2019). TCDD is suggested to share a signaling pathway with all-trans-retinoic 
acid (atRA) because TCDD fails to induce cleft palate when atRA signaling is impaired (Jacobs 
et al., 2011).  
 
The Extracellular matrix in palatogenesis 
The extracellular matrix (ECM) plays an important role in embryonic development, 
homeostasis, and tissue repair. The increasing knowledge about the ECM is beginning to bridge 
the gap between the traditional surgical methods and the tissue regeneration approach for 
repairing the cleft palate. In the ECM, there are structural molecules attached to the cell 
membrane and soluble factors (Paiva et al., 2019). One broad category of membrane protein, 
called the secretome, is in charge of interacting with the ECM and secreting molecules to the 
ECM. These molecules could either be in soluble forms or secreted into vesicles called 
extracellular vesicles (EVs). Matrisomes describe a board category of proteins found inside the 
secretome, which consist of ECM-proteins, also known as the core matrisomes and ECM-
associated proteins (matrisomes-associated). The core matrisomes contain fibrous proteins and 
proteoglycans, while the matrisomes-associated proteins include ECM-related proteins, soluble 
factors, and ECM regulators (enzymes). Fibrous proteins, such as collagen and elastin provide 
the matrisomes with structural support, and the fibronectin, laminin, nidogen, and vitronectin 
carry out adhesive properties. These macromolecules have been found to communicate with each 
other and bind to growth factors (Raghunathan et al., 2019). The matrisomes-associated proteins 
function to modulate the ECM and are encoded by approximately 700 genes, making up 4% of 
the human genome (Hynes et al., 2012).  
The other component of the core matrisomes, proteoglycans, are proteins conjugated to 
glycosaminoglycans (GAGs). GAGs are highly negatively-charged molecules that attract 
positively-charged sodium ions, and subsequently, water, which maintains viscosity and 
preventing desiccation. It was found that the ECM also contains a high level of hyaluronic acid 
or hyaluronan (HA), a GAG without sulfate (Garantziotis et al., 2019).  
During early stages of development, tissue repair, and disease, the ECM components 
transition from their initial state to a tissue-specific makeup. This transitory state, called the 
provisional matrix, is formed by fibrin, fibrinogen, fibronectin, HA, and versican, a large 
chondroitin sulfate proteoglycan. HA interacts with CD44, a membrane receptor, to provide 
structure, or “glue” that brings together all other components in the pericellular space. The 
provisional matrix is considered viscoelastic, a property that allows the ECM to create space for 
cell migration. This is why the migration route of the neural crest cells express high levels of 
versican (Barker et al., 2017; Chester et al., 2017). Tenasin, another type of ECM protein, is 
expressed in embyroic cells involved in the neural crest cell migration pathways in mammalian. 
Tenasin is found to be upregulated in response to epithelio-mesenchymal interactions and is 
highly restricted during vertebrate development (Riou et al., 1992; Barker et al., 2017; Chester et 
al., 2017). During development, the palate elevates due to its intrinsic “internal shelf force,” at 
which time, HA is found to be the most abundant GAG in palatal ECM. Specific enzymes on the 
cell surface are found to produce HA. It is worth noting that these enzymes are unique to the 
tissue of the embryonic palatal mesenchyme (derived from neural crest cells) and epithelium and 
exhibit a differentiated expression of the involving genes (Galloway et al., 2013; Paiva et al., 
2019). Fibronectin, another component of the provisional matrix, is observed to be elevated in 
areas of cell migration during palatogenesis and also responsible for palatal shelf elevation 
(Schwarzbauer et al., 2011; Tang et al., 2015).  
Soluble factors are well-known as a form of cellular communication. Cell surface 
proteins and receptors receive signal from soluble factors from the ECM and help achieve cell-
cell interactions including juxtracrine, autocrine, paracrine, and endocrine signaling (Ansorge et 
al., 2018). Many different forms of cell-cell interactions occur during development. Local 
mediators, such as peptides and growth factors are common in controlling cellular activities. 
Morphogens, a type of mediators, are known to induce specific cell differentiation in a specific 
spatial pattern using its varying concentration gradient (Inomata, 2017). Recently, microRNAs 
(miRNAs), a class of small regulatory non-coding RNA molecules, have been identified as key 
regulators in palatogenesis. MiRNAs have shown to play a role in both normal development as 
well as cleft palate formation. MiRNAs may act as post-transcriptional repressors, or the “fine-
tune” mechanism, of certain gene expression involved in the palatogenesis pathway (Schoen et 
al., 2017).  
 
Mechanisms of ECM remodeling 
The ECM environment is dynamic, both during development and later in life. Post-
transcriptional modifications, including collagen-collagen, collagen-ECM, and ECM-ECM, are 
often referred to as ECM cross-links. ECM cross-links are important interactions for structural 
support in the microenvironment. When first formed, cross-links are immature and prone to 
proteolytic degradation; cross-links will improve stability once they generate insoluble proteins 
polymers and establish a stronger collagen network with better biomechanical properties. The 
modeling and remodeling of the ECM is determined by the soluble or EV-associated proteases 
secreted into the ECM or membrane-bound proteases, considered a class of cross-linkers (Paiva 
et al., 2019; Sanderson et al., 2019).  
 During palatogenesis, the development of the facial primordia is achieved by the 
remodeling of the ECM. Many genes and enzymes have been shown to participate in this 
process, most of which belong in the metzincin family of metalloproteinases (Stöcker et al., 
1995). One member of the family, the vertebrate matrixins (MMPs) are most studied for their 
ability to degrade all ECM components (Bond, 2019). During development, MMPs participate in 
the process of morphogenesis through their ability to modify the components in the existing 
ECM, allowing cell migration and differentiation, tissue resorption, and cell-cell interactions. 
The ECM remodeling process is crucial for palatal shelf orientation and the epithelial-to-
mesenchymal transition (EMT) during palatal fusion (Brown et al., 2002). The tissue inhibitors 
of metalloproteinases (TIMPs) are another class of enzymes that are upregulated and distributed 
in a similar spatial pattern to the MMPs in cells of the epithelial basement membrane (Morris-
Wiman et al., 2000). TIMPs are shown to be associated with ECM structural integrity and 
rigidity by inhibiting the MMPs and similar enzymes such as the ADAM (A Disintegrin And 
Metalloproteinase) and ADAMTS (A Disintegrin-like And Metalloproteinase with 
ThromboSpondin motifs) (Sahebjam et al., 2007; Paiva et al., 2019). Palatal fusion involves the 
disintegration of the basement membrane, the EMT process, and the migration and adhesion of 
the differentiated mesenchymal cells to the adjacent side, all of which involve matrix 
metalloproteinases. The involved epithelial cells are shown to also express genes encoding 
matrix metalloproteinases (Horejs, 2016). It is worth noting that research has shown possible 
compensatory mechanisms for these crucial genes in palatogenesis, because the single knockouts 
for many genes in the TIMPs and MMPs family do not lead to development of cleft palate (Paiva 
et al., 2014). While individual, loss-of-function MMPs may be compensated for, the loss of 
multiple specific MMP genes in combination may interfere with normal palatogenesis. It is also 
suspected that MMP genes may play a role in interacting with and modifying other genes 
involved in the palatogenesis pathways (Paiva et al., 2019).  
 Proteomics has been the most popular strategy in characterizing ECM components in 
both normal development and pathological conditions. One of the biggest challenges to 
proteomics in the past has been the solubilization and protein recovery, until an optimized 
protocol was developed (Paiva et al., 2019). The proteins in the ECM matrix can be now 
digested into peptides before analyzed using mass spectroscopy, and web tools are used to 
annotate and quantify ECM proteins relative to each other. This new development contributed to 
faster results and analyzing the changing expression of ECM proteins during development and 
remodeling (Naba et al., 2017).  
 ECM remodeling plays an important role in embryonic palatogenesis. Growth factors and 
other molecules involved in the ECM remodeling progress suggest promising future directions 
for novel ways of palatal reconstruction and regeneration. Two of the most important families of 
genes involved in ECM remodeling are the MMPs and TIMPs, both enzymes of the 
metalloproteinase family. The MMPs are shown to be involved in ECM degradation, making 
room for cell migration and differentiation during palatal fusion. The TIMPs are shown to inhibit 
the activity from MMPs as well as other similar enzymes in the ECM. Research failed to show 
cleft palate development due to MMP single knockouts, suggesting a compensatory mechanism 
in vivo. However, the loss of function of a combination of specific MMPs are likely to cause 
impaired palatal development in embryo.  
  
Methods of palatal reconstruction   
 Palatal reconstruction is the term used to define “any intervention able to restore the 
barrier between the oral and nasal cavities, and physiological functions” (Paiva et al., 2019). The 
most traditional method of repair for the cleft palate and lip involves plastic surgery for the lip 
and a bone graft for the palate. Orthodontist treatment is often needed and delivered in multiple 
stages throughout development. Depending on each unique patient’s case, a multidisciplinary 
team of surgeons, dentists, speech pathologists, geneticists, and nutrition experts may be 
involved in delivering care. Without adequate care, the cleft palate with or without cleft lip may 
result in difficulty in deglutition, breathing, speech, and hearing. Surgical repair of the cleft lip, 
cheiloplasty, usually occurs 3 months after birth, followed by palatoplasty, surgical repair of the 
cleft palate, in the first 6-12 months of life. Bone grafts, when needed, are usually delivered 
between 8-11 years of life. Orthodontist treatment may be necessary anytime between the second 
year of life and early adulthood. The variability in the type and the timing of the treatment is 
dependent on the severity of the cleft and the extension of the tissue loss (Paiva et al., 2019). 
 Among all different types of bone grafts, the autogenous bone grafts are considered the 
gold standard for repairing the alveolar bone and reconstructing the palatal structure. In some 
cases, multiple grafts, divided into treatment stages, may be necessary. Craniofacial bone and 
noncraniofacial bone present different embryonic origins. As illustrated above, craniofacial 
bones and cartilages were formed from the mesenchymal cells that derived from the neural crest 
cells, while the bones in the axial skeleton came from the somites and the lateral plate mesoderm. 
Most of the bones of the skull are flat bones and are known to undergo intramembranous 
ossification, a process in which mesenchymal cells are directly converted to bone. In contrast to 
intramembranous ossification, endochondral ossification involves an extra step as mesenchymal 
cells becomes cartilage first before converted into bone. Many parts of the appendicular skeleton 
in the body, such as the femur, are categorized as long bones and would undergo endochondral 
ossification in embryo (Zhang et al., 2018).  
Craniofacial and noncraniofacial bones show different homeostatic mechanisms, and 
membranous bone grafts were found to retain volume better than endochondral bone grafts (Zins 
et al., 1984). That’s why the most commonly used donor sites include the anterior iliac crest, 
proximal tibia, mandibular symphysis, calvaria, and ribs, some examples of bones derived from 
the mesoderm. One of the biggest disadvantages of autogenous bone grafts stems from the 
limited bone volume available to harvest as well as potential morbidity at the donor site. Post-
surgical complications may involve symptoms such as chronic pain, paresthesia of the thigh, and 
hypertrophic scarring. Unsuccessful repairs are often associated with the loss of the graft due to 
inflammation, bone resorption, and the development of oronasal fistulas (Borba et al., 2014). 
 Over the years, studies have investigated many alternatives to repair the cleft palate. 
Following the first generation of palatal reconstruction using autogenic bone grafts, the second 
generation of palatal reconstruction utilizes biomaterials and growth factors. Osteoconductive 
biomaterials including hydroxyapatite and tricalcium phosphate were introduced as an alternative 
to allogeneic, xenogeneic, and alloplastic grafts. Growth factors such as the BMPs, “natural 
adjuvant” platelet concentrates, denominated platelet-rich plasma (PRP), and platelet-rich fibrin 
(PRF) were used in combination with various biomaterials (Paiva et al., 2019). Specifically, 
BMP-2 has demonstrated an increase in the production of mature bone both in vitro and in vivo 
(Shimakura et al., 2003). Clinical studies demonstrated that BMPs are as efficient as autologous 
bone graft for the repair of the cleft palate and alveolar bone (Hammoudeh et al., 2017).  
Cell-based therapies have been investigated as another alternative to repair the cleft 
palate and alveolar bone. These methods involve stem cells that are able to differentiate into 
active osteoblasts to promote bone growth and regeneration (Fallucco et al., 2009; Paiva et al., 
2019). Two studies done in 2018 and 2019 found no statistical difference between the role of 
BMP2 and the tissue-engineered bone replacement materials in repairing the palate and alveolar 
clefts (Kamal et al., 2018; Paiva et al., 2019; Scalzone et al., 2019). One meta-analysis conducted 
in 2018 compared iliac crest bone grafts (ICBG) with BMP-2, acellular dermis matrix 
membrane, cranium, and rib grafts; when BMP-2 was bound to absorbable collagen sponge, it 
showed a similar cleft repair efficacy to ICBG; covering ICBG with acellular dermis matrix was 
shown to increase bone retention for unilateral cleft patients; mixing ICBG with plasma may 
increase bone retention for skeletally mature patients but not for younger patients; and that the 
mandible graft is more effective than cranium and rib grafts for alveolar cleft reconstruction; 
ICBG is still shown to be one of the best courses of treatment based on patient outcomes (Wu et 
al.). 
 The third generation of palatal reconstruction was made possible due to the recent 
advancements in three-dimensional (3D) cell culture techniques. Tissue and ECM remodeling 
and palatal fusion occur in a three-dimensional environment, so 3D cell cultures more closely 
mimic realistic cell morphology, physiology, and pathology. This technology not only offers 
novel ways to study and observe embryonic development, but also another alternative to palatal 
reconstruction without the need of scaffolding. Three-dimensional cell cultures are considered 
4D when time is taken into consideration (Paiva et al., 2019). To create a 3D cell culture, one 
may utilize cell aggregates, spheroid, or organoids (Alhaque et al., 2018).  
 Palatal reconstruction using stem cells, biomaterials, scaffolds, and signaling molecules 
could be divided into two main approaches. The “top-down” approach takes place in vitro and 
involves producing functional tissue using proliferating cells within scaffolding biomaterials. 
The “bottom-up” approach takes place in vivo and produce modular tissue units (spheroids) from 
adult stem cells that are responsible for synthesizing their own ECM (Baptista et al., 2018). 
Research in cleft palate repair using bone bioengineering is still in its infancy stage, with very 
few studies using animal models. However, more studies have been conducted for repairing 
alveolar clefts or mid-palate cleft. Several studies have shown a successful mid-palate repair in 
animal models using human stem cells. For example, one study uses the rat model and 
demonstrated filling a palatal defect using an autogenous engineered graft. The authors used fat-
derived stem cells that were differentiated into osteoblasts/osteocytes and seeded onto a poly-L-
lactic acid absorbable scaffolds (Conejero et al., 2006). A more recent study demonstrated the 
use of a type of autogenous multilayered palate substitute with bone and oral mucosa tissue to 
repair palatal defects in the rabbit model. In this study, adipose tissue-derived mesenchymal stem 
cells (MSCs) were divided into individual cell layers and seeded onto fibrin-agarose hydrogels to 
induce differentiation into osteogenic cells. Fibroblasts and keratinocytes were also seeded onto 
the same gel. The oral mucosa layer was placed on top and compressed to fuse the mucosal 
stroma (fibroblasts) with the osteogenic layer. Partial bone differentiation was observed. The 
authors suggest the multilayered approach may result in an increase in maturation time when 
compared to monolayered approaches in vivo (Martín-Piedra et al., 2017).  
 
 
 
Types of stem cells proposed for craniofacial reconstruction 
 Bone-marrow stem cells (BMSCs) are one of the most studied topics in regenerative 
medicine, and their cell properties are relatively well-known. However, it remains unknown in 
terms of the specifics of how to prepare BMSCs ex vivo before their differentiation process and 
clinical application (Shanbhag et al., 2019). Scaffold-free BMSCs are considered safe to use to 
repair alveolar clefts in CL/P patients, but not more extensive bone defects (Bajestan et al., 
2017). However, the use of BMSCs still requires a donor site (primarily at the iliac crest) and do 
not overcome the challenge of donor site morbidity observed in regular autogenous bone grafts, 
even when minimally invasive techniques are used (Paiva et al., 2019).  
 Because the use of BMSCs can still lead to donor site morbidity, researchers started 
looking for alternative sources for mesenchymal stem cells (MSCs). The MSCs found in adult 
dental tissues display cranial neural crest cell (NCC) properties and are more closely related to 
cells involved in palatogenesis in the embryo than BMSCs from other areas in the body (Dixin et 
al., 2018). In the mouth, human MSCs could appear in tissues with both odontogenic and non-
odontogenic origins, and may be harvested during a wide range of surgical procedures. Among 
cells from non-odontogenic origins, those that display MSC and osteogenic properties have been 
observed in gingival connective tissue, also known as gingival mesenchymal stem/progenitor 
cells (GMSCs) (Yang et al., 2013), oral periosteum of the palate, the lower and upper vestibule 
(Ceccarelli et al., 2016), palatal connective tissue (Pall et al., 2017), and adipose stem cells from 
buccal fat pad (Farre Guasch et al., 2010). A recent study in 2019 demonstrated the retention of 
stem cell properties of palatal periosteum-derived MSCs (Naung et al., 2019). In a registered 
clinical trial aimed to repair human alveolar clefts, the researchers found no statistical difference 
among three random groups: 1) using anterior iliac crest (AIC) bone and a collagen membrane; 
2) lateral ramus cortical plate with buccal fat pad derived mesenchymal stem cells (BFSCs) 
mounted on a natural bovine bone mineral; and 3) both AIC and BFSCs cultured on natural 
bovine bone mineral with a collagen membrane (Khojasteh et al., 2017). However, this approach 
still does not resolve the issue of limited amount of tissue available as presented in other types of 
autogenous grafts.  
 Five different types of MSCs have been identified in various locations in dental tissues: 
dental follicle progenitor stem cells (DFPSCs), stem cells from apical papilla (SCAPs), 
periodontal ligament stem cells (PDLSCs), dental pulp stem cells (DPSCs), and stem cells from 
exfoliated deciduous teeth (SHEDs) (Baniebrahimi et al., 2019). Because it is a natural part of 
development to exfoliate SHEDs, they are considered the most obtainable odontogenic tissue 
with little to no harm to the donor site. The pulp tissue may be harvest between 5 and 12 years of 
age, when a child’s deciduous teeth are replaced by permeant ones, and this procedure is not 
considered to be associated with significant ethical implications (Taguchi et al., 2019). 
Furthermore, SHEDs are highly proliferative, display a capacity to differentiate across multiple 
linages, and are known to secret immunomodulatory molecules. Similar to SHEDs, DPSCs may 
be harvested during the extraction procedures of third molars, a procedure often done in young 
adults and adolescents, presenting another example of sources to obtain MSCs with little to no 
known ethical implications (Yamada et al., 2019). Both SHEDs and DPSCs allow cell sheets 
(Lee et al., 2019) and 3D spheroid cultures (Wang et al., 2010). Both types of stem cells display 
high regenerative potential because they express high levels of secretome as well as many types 
of paracrine soluble molecules and EVs. It is worth noting that they present potential in many 
different areas of regenerative medicine, including cells involved in the immune system, 
neurons, and vasculature (Kichenbrand, 2019; Paiva et al., 2019).  
 Compared to using MSCs and BMSCs, SHEDs were proposed to be better alternatives 
for craniofacial bone repair in one study. The SHEDs were primed using FGF-2 and/or hypoxia 
to improve angiogenesis (Novais et al., 2019). Systematic reviews evaluating methods using 
bioengineered PDSCs and SHEDs to repair bone defects in both humans and mice showed 
promising results (Leyendecker Junior et al., 2018). In European countries, biobanks were 
established to collect and store healthy exfoliated teeth as a lower-cost alternative to umbilical 
cord banks. However, stems cells obtained from PDSCs and SHEDs still require ex vivo 
manipulation, an unavoidable time-consuming and costly procedure as another challenge the 
scientific community is still yet to overcome (Paiva et al., 2019). 
 Another proposed source of MSCs comes from the orbicularis oris muscle incised during 
the cheiloplasty procedure of CL/P patients. The orbicularis oris muscle is a circular muscle that 
surrounds the lips and is responsible for lip movements. It is usually discarded after the initial 
surgery repair of the cleft lip. Research demonstrated that these muscle cells have the potential to 
express classical MSC cell surface proteins as well as differentiate into multiple different tissue 
lineages in vitro, including bone, fat, cartilage, and skeletal muscle (Paiva et al., 2019).  
 Adipose-derived mesenchymal cells (AMCs) are another potential candidate for bone 
regeneration. The biggest advantage of AMCs are their accessibility and availability in large 
amounts. AMCs were demonstrated to have similar growth kinetics and cell senescence as 
BMSCs isolated from the same donor (De Ugarte et al., 2003). Various types of scaffolding have 
been investigated to work with AMCs in regenerating craniofacial bone in animal models. For 
example, one of the more recent studies showed bone regeneration in a critical-sized calvarial 
defect in mice using silk scaffolding (Jin, 2014).  
 
Technology in bioengineering and regenerative medicine  
Computer-Aided Design (CAD) is widely used in many areas in dental medicine, such as 
the planning of implants, crowns, and orthodontist treatments, and facial reconstruction is no 
exception. Due to the complexity of the craniofacial structures, minor bone resorption could lead 
to less than desirable outcomes from reconstructive surgery. CAD provides more accurate 
strategies to craniofacial reconstruction (Zhang et al., 2018). Titanium scaffolds have been 
suggested for an alternative candidate in craniofacial reconstructive surgery due to their 
nonabsorbable properties (Terheyden et al., 2004). Titanium cages filled with granules, 
cancellous bone chips, or bone blocks in conjunction with adipose-derive stem cells (ASCs)  
have demonstrated success in repairing large craniofacial defects (Zhang et al., 2018). 
 Thanks to the evolving technology that gave rise to three-dimensional (3D) printing, 3D 
biomimetic scaffolds were made possible in regenerative medicine. Scaffolds serve as a method 
of delivery of progenitor cells and growth factors in surgical sites, mimicking the ECM 
composition of craniofacial bone (Zaky et al., 2014; Teven et al., 2015). A well-designed 
scaffold should be easy to implant in vivo, and support cellular adhesion and proliferation (Zaky 
et al., 2014). Many types of material have been proposed and investigated for possible clinical 
application, each representing unique strengths and drawbacks. Three broad categories arise 
from all scaffolds that have been investigated for craniofacial regeneration: polymer-based 
scaffolds, calcium phosphate-based scaffolds, and composite scaffolds. Within the polymer-
based scaffolds, natural polymers such as chitosan and silk fibroin have been demonstrated to 
produce promising results; synthetic polymers such as poly(lactic acid) and poly(glycolic acid) 
and poly(e-caprolactone) have been synthesized to support osteoblastic functions. Calcium 
phosphate-based ceramic scaffolds includes hydroxyapatite and -tricalcium phosphate materials 
(Teven et al., 2015). Composite scaffolds usually comprise both polymer-based and calcium-
phosphate-based materials to take advantage of the best in both worlds. The ceramic-based 
scaffolds are superior in their biocompatibility, osteoconduction, and mechanical strengths. 
Polymer-based scaffolds are slower in degradation rate and relatively easier for structural 
manipulation (Rezwan et al., 2006).   
  Currently, 3D printing techniques allow researchers to print cells directly, biomaterials 
with cells, or scaffold-free cell aggregates. For tissue regeneration, three types of 3D printers are 
commercially available: inkjet printers, laser-based printers, and microextrusion printers (Zhang 
et al., 2018). While laser-based printers and microextrusion printers have been used to fabricate 
tissues such as vascular trees and cellularized skin, inkjet printers are the only ones that have 
been shown to be able to successfully fabricate bone tissue. Inkjet bioprinters are relatively time-
efficient, use a “drop-on-demand” process, and can be customized to the individual patient’s 
needs each time (Azuma et al., 2014). For rapid functional recovery, it would be beneficial to 
regenerate hard and soft tissue simultaneously, an area of craniofacial regenerative medicine that 
is still under investigation. It has been suggested that dental tissue may be regenerated 
simultaneous with mandibular or maxillary bone in the future (Zhang et al., 2018). 
 One of the biggest challenges in 3D bioprinting is the limitation on the size of the 
structure. Hydrogel, the most popular injecting material, fails to provide stable structural support 
for bone and/or tissue structures that are of clinically relevant size (Chang et al., 2011). To 
overcome this challenge, a new tissue-organ printer (ITOP) has been developed to generate 
larger tissue structures suitable for regenerative medicine. The ITOP achieves mechanical 
stability by printing cell-laden hydrogel integrated with biodegradable polymers onto sacrificial 
hydrogels. CAD imaging data is used to establish the correct shape of the tissue. The anatomical 
defect is scanned and entered into a computer program to ensure cells are dropped into correct 
locations. Microchannels are incorporated into the tissue to diffuse nutrients to printed cells to 
overcome the previous challenge of having a diffusion limit of 100-200 um for cell survival. The 
developers of ITOP was able to demonstrate fabricating mandible and calvarial bone, cartilage, 
and skeletal muscle (Kang et al., 2016). 
 
Soft tissue regeneration in the palate 
Not all CLP patients present with the cleft in the soft palate. Soft palate clefts are 
associated with difficulty in speech, swallowing, sucking, and the inability to separate the nasal 
cavity from the oral cavity (velopharyngeal dysfunction). Traditional surgical repair usually 
involves closing the cleft and reconstructing the muscle levator veli palitini (LVP), the major 
muscle of the soft palate (Boorman et al., 1985). However, approximately 10-30% of patients fail 
to achieve adequate velopharyngeal function post-surgery, mainly due to three main factors. The 
muscles in the soft palate presents intrinsically low regenerative capacity compared to skeletal 
muscles on the limb; the formation of the cleft in the soft palate in embryo usually leads to the 
dysfunctional organization of the muscles; and the development of fibrosis post-surgery 
(Carvajal Monroy et al., 2012).  
In normal development, five pairs of muscles should arise to form the soft palate: the 
tensor veli palatini (TVP), the LVP, the palatopharyngeus (PP), the palatoglossus (PG), and the 
uvulae (U). All muscles, with the exception of U, which is an intrinsic muscle without bony 
attachment, extend from separate bony structures but share the same insertion at palatal 
aponeurosis (PA), near the center of the soft palate. When a cleft forms in the soft palate, PA is 
divided in half, each shifted to the lateral sides of the soft palate, giving rise to an abnormal 
insertions for the four pairs of aforementioned soft palate muscles (Figure 5). Because the 
muscles now have two instead of one skeletal attachment, they present limited isometric 
contractions (Hubertus Koch et al., 1999). Without treatment, the cleft muscles could further 
widen the gap as they pull the two halves of the soft palate superiorly and laterally (Fara et al., 
1970). The LVP may undergo atrophy due to the lack of stimulation (Cohen et al., 1994).  
 
 
Figure 5. The comparison of the soft palate muscles in normal development vs. in a cleft palate 
patient. The soft palate consists of five pairs of muscles: the tensor veli palatini (TVP), the 
levator veli palitini (LVP), the palatopharyngeus (PP), the palatoglossus (PG), and the uvulae 
(U). Palatal aponeurosis (PA) is the normal insertion of four pairs of muscles with the exception 
of U. PA is split into two structures if cleft is present in the soft palate. Cleft palate muscles are 
often underdeveloped and show disorganized myofibers due to the abnormal insertion near the 
posterior border of the hard palate (Carvajal Monroy et al., 2012).  
 
  
 All skeletal muscles may be divided into categories of slow or fast twitch. Slow twitch 
muscle fibers have a low activation threshold and are resistant to fatigue while fast twitch muscle 
fibers have a higher activation threshold and are more fatigable. Slow twitch muscles are more 
likely to undergo a larger proportion of aerobic metabolism while fast twitch fibers are more 
prone to carry out anaerobic metabolism. As a result, slow twitch muscles fibers usually require 
more blood supply and appear red. Normal LVP muscle contains predominantly slow fibers, 
while LVP in the cleft palate shows a higher proportion of fast fibers and a reduced capillary 
supply (Lindman et al., 2001). This increased proportion of fast fibers explain why the LVP may 
easily become fatigued during speech in cleft patients (Hanes et al., 2007). Fast fibers are also 
more prone to contraction-induced injury (Rader et al., 2007).  
 Unlike skeletal muscles of the limb, the muscles in the soft palate do not regenerate as 
readily. Most studies on muscle regeneration are done in the limb muscles instead of the head 
muscle. Satellite cells, known as the primary muscle stem cells, are responsible for muscle 
growth and repair after birth (Mauro, 1961). Previously, the difference in cell lineage and origin 
between the bones of the head and the rest of the skeleton was discussed. Similarly, the muscles 
in the head present a difference in origin compared to the muscles of the trunk and limbs. The 
muscles of the head are derived from the branchial arches (branchiomeric muscles), while the 
rest of the skeletal muscles in the body are derived from the somites (Christ et al., 1995; Noden 
et al., 2006). One study done on the masseter muscle found a reduced number of satellite cells in 
the masseter muscle, another example of branchiomeric muscle similar to the muscles of the soft 
palate (Ono et al., 2010). Furthermore, satellite cells are found to be significantly less numerous 
in fast fibers than slow fibers, another factor causing a decrease in satellite cell number in cleft 
palate muscles (Gibson et al., 1982).  
 One of the three reasons attributing to less desirable outcomes after surgical repair of the 
soft palate is the intrinsically low regenerative properties of the muscles. It has been suggested 
that isolated satellite cells may be transplanted into the soft palate muscles for improved 
regeneration (Carvajal Monroy et al., 2012). Transplanted satellite cells have demonstrated 
success in stimulating muscle tissue to proliferate and renew in patients with diseases such as 
Muscular Dystrophy (Motohashi et al., 2014). However, transplanting satellite cells and 
myoblasts is not without limitations. After isolation, satellite cells may lose their regenerative 
capacity in culture; they only demonstrate limited survival rates after injection; and their ability 
to migrate to injury site is also limited (Ferrari et al., 1998).  
 Alternative to the transplantation approach, the preexisting satellite cells in the soft palate 
muscle may be stimulated and recruited by growth factors to proliferate and differentiate. 
Examples of relevant growth factors include insulin-like growth factor 1 (IGF-1) and FGF-2 
(Carvajal Monroy et al., 2012). To combat diffusion and enzymatic inactivation, these growth 
factor may not simply be injected. They are the most effective when incorporated into 
biodegradable scaffolds for a more controlled release (Whitaker et al., 2001). For soft palate 
muscle regeneration, the use of growth factors with the appropriate delivery system is more 
likely to yield desirable results than cell-based therapy (Carvajal Monroy et al., 2012).  
 Disorganization of the muscle fibers is the second major factor causing nonfunctional soft 
palate muscle post-surgery. Both scaffolding and surface topography may help achieve better 
alignment of the soft palate muscles after repair. Surface topography is a method in tissue 
engineering used to align skeletal muscle fibers. It usually involves a polymer chip with linearly 
aligned microgrooves that guide myoblast to form unidirectionally aligned juxtaposed myotubes 
(Zhao et al., 2009). Other techniques to control cellular alignment includes electrospinning, 
photolithography, and electron mean lithography (Carvajal Monroy et al., 2012). Growth factors 
may be printed on sub-micron polystyrene fibers that guides the direction of myoblast activity at 
the same time (Ker et al., 2011). One challenge with using biodegradable materials and 
scaffolding is making sure that the material degrades before significant growth of the patient 
occurs, since reconstructive surgery is usually performed in children (Carvajal Monroy et al., 
2012).  
 Lastly, fibrosis that occurs post-surgery may impair muscle function. During 
regeneration, the extracellular matrix (ECM) expresses transforming growth factor-beta 1 (TGF- 
1). Myoblasts that expresses the TGF- 1 gene can differentiate into myofibroblast cells that 
stimulate scar formation (Li et al., 2004). Naturally, the solution proposed is to inhibit the 
activity of TGF- 1. Examples include decorin, a member of the small leucine-rich proteoglycan 
family that reduces TGF- 1 and its synergist, myostatin (Zhu et al., 2007). Further research in 
other signaling molecules such as nitric oxide is required. Nitric oxide was been shown to down 
regulate TGF- 1 activity, but its role in muscle regeneration remains unclear (Filippin et al., 
2011).  
 In conclusion, improved muscle regeneration in the soft palate leads to better surgical 
outcome in repairing the cleft soft palate. In cleft palate patients, the soft palate muscles do not 
regenerate as readily, which calls for growth factors in suitable delivery systems such as a 
polymer scaffolding. The scaffolds may also offer architecture and guidance for myoblast 
activity, making sure that the new muscle fibers generated are properly aligned. Scar tissue, also 
known as fibrosis formation may be avoided using factors such as decorin.  
 
  
Conclusions and future directions  
Orofacial clefting is one of the most common birth defects, and a team of specialists is 
usually required to treat one patient. All cleft palate cases may divided into three categories: 
isolated cleft lip and/or alveolus; isolated cleft palate; and combined cleft lip, alveolus, and 
palate. Each of the three main categories may be further divided based on the severity of the 
clefts as complete or incomplete, and unilateral or bilateral. There are many possible causes for 
the cleft palate, including genetic and environmental factors. It could either occur as the only 
birth defect (non-syndromic) or as a part of a syndrome such as the DiGeorge syndrome.  
The human palate is divided into the hard (anterior) and the soft (posterior) palate, with 
the incisive foramen further dividing the hard palate into the primary (anterior) and the 
secondary (posterior) palate. The palate develops between the 4th and the 12th to 13th weeks after 
conception in the human embryo. In normal development, five pairs of bilaterally symmetric 
protrusions (branchial arches) extends laterally to approach the midline on the ventral side. Cells 
in facial development are largely neural crest cells, with some others from lineages such as the 
mesenchyme, mesoderm, ectoderm, and endoderm, depending on their physical location. As the 
branchial arches from each side fuse into one, the migrating neural crest cells undergo the 
epithelial-to-mesenchymal transition (EMT), one of the most important events in facial 
development. The neural crest cells receive signals from surrounding epithelial tissues, the 
fibroblast growth factor (FGF), bone morphogenetic protein (BMP) families, sonic hedgehog 
(SHH), and components of the endothelial signaling pathway. Genes such as the Tbx1 gene, 
homeobox transcription factors (MSX1, MSX2), NOGGIN (NOG), Nectin1 (PVRL1 gene) are 
known to influence cellular changes that allows the branchial arches to fuse and transform into 
one, confluent mesenchymal cell layer with structural integrity. The cleft palate may also occur 
due to environmental teratogens and nutritional deficiencies and excesses. Oxidative stress, 
retinoic acid, and environmental toxins such as TCDD has been shown to cause cleft palate in 
animal models.  
The extracellular matrix (ECM) plays an important role in cell regulation both in the 
embryo and maintaining homeostasis after birth. Cell-cell communication are achieved through 
juxtracrine, autocrine, paracrine, and endocrine signaling, soluble factors carried to cell receptors 
via the ECM. Research about ECM proteins, signaling molecules, and cellular pathways not only 
revels causes for CLP, but also offers possibilities in tissue engineering and regeneration as 
novel methods of cleft palate repair. Secretomes are a board category of membrane protein that 
interacts with and secrets molecules into the ECM. Inside secretomes are matrisomes. 
Matrisome-associated proteins include ECM-related proteins, soluble factors, and ECM 
regulators (enzymes). The ECM creates space for cell migration during palatogenesis through 
manipulating each ECM components to appropriate levels. Local mediators, peptides, growth 
factors, and microRNAs work concurrently to arrange cell patterns and induce differentiation 
during palatogenesis.  
Remodeling of the ECM during palatogenesis involves many genes and enzymes, many 
of which belong in the metzincin family of metalloproteinases. The ECM remains a dynamic 
environment through two opposing forces of building up and breaking down. Enzymes such as 
Matrixins (MMPs) are known to degrade ECM components, while the tissue inhibitors of 
metalloproteinases (TIMPs) are known to increase rigidity of the ECM by inhibiting the MMPs. 
ECM components in both normal development and pathological conditions may be studied 
through novel proteomics methods involving digesting the proteins into peptides before 
analyzing using mass spectroscopy.  
The most popular method in cleft palate repair and reconstruction to date is one or 
multiple autogenous bone grafts (first generation of palatal reconstruction). Compared to other 
bones in the body, craniofacial bones are different in cell lineage, as they are derived from neural 
crest cells that later transitioned into mesenchymal cells in embryo. Bone in the body are derived 
from somites. Furthermore, craniofacial bones are mostly flat bones that underwent 
intramembranous ossification as opposed to long bones that underwent endochondral 
ossification, such as the femur. For this reason, flat bones such as the anterior iliac crest are often 
used as donor sites for cleft palate repair. Some of the biggest challenges with autogenous bone 
grafts re the limited bone volume and donor site morbidity. Post-surgical complications may 
include chronic pain of the donor site or even the loss of the graft due to inflammation, bone 
resorption, and the development of oronasal fistulas.  
To better patient outcome, the second generation of palatal construction utilizes 
biomaterials and growth factors. Osteoconductive biomaterials such as the hydroxyapatite are 
used in conjunction with growth factors such as the bone morphogenetic protein (BMPs). 
However, this method and those similar to it did not prove to be significantly more effective than 
traditional autogenous bone grafts. The third generation of palatal reconstruction arose with the 
3D cell culture techniques. Cell aggregates, spheroid, and organoids closely mimics real cell 
morphology, physiology, and pathology.  
Tissue-engineering in palatal reconstruction may be divided into the “top-down” and the 
“bottom-up” approach. The “top-down” approach takes place in vitro and involves producing 
functional tissue using proliferating cells within scaffolding biomaterials. The “bottom-up” 
approach takes place in vivo and produces modular tissue units (spheroids) from adult stem cells 
that are responsible for synthesizing their own ECM. Bone bioengineering research is still 
largely in its infancy stage, with little to no clinical data from human trials.  
Many different types of stem cells may be used for palatal reconstruction, including 
bone-marrow stem cells (BMSCs), mesenchymal cell cells (MSCs), gingival mesenchymal 
stem/progenitor cells (GMSCs), adipose-derived mesenchymal cells (AMCs) and stem cell 
located in dental tissues: dental follicle progenitor stem cells (DFPSCs), stem cells from apical 
papilla (SCAPs), periodontal ligament stem cells (PDLSCs), dental pulp stem cells (DPSCs), and 
stem cells from exfoliated deciduous teeth (SHEDs). Because the exfoliation of SHEDs is a 
natural part of development, they are much more easily obtainable than autogenous bone grafts 
and some other sources of stem cells. Both SHEDs and DPSCs allow cell sheets and 3D spheroid 
cultures, showing their promising future in many different areas of regenerative medicine. 
However, more research is still required before stem cell therapy becomes widely and routinely 
used in palatal reconstruction.  
Recent advancements in biotechnology also open new possibilities in craniofacial 
reconstruction. Computer-aided design (CAD) is widely used in many areas of dentistry 
including facial reconstruction. CAD provides more accurate measurements and planning that is 
required to reconstruct complex structures such as the face. Three-dimensional printing made it 
possible to fabricate biomimetic scaffolds of various materials, to print cells directly as 
aggregates, or biomaterials with cells. Tissue-organ printer (ITOP) allows tissues of any size to 
be printed, different from the previous 3D printers that failed to provide enough structural 
support to print tissue that are large enough to be clinically relevant. Similarly to stem cell-based 
therapy, the ITOP technology still needs time in the research lab before entering the operating 
room.  
Lastly, the muscles of the soft palate sometimes may not obtain full function after cleft 
palate repair due to the intrinsically limited regenerative properties of the muscles, the disrupted 
organization of the muscle fibers due to the abnormal insertion in a cleft palate, and scar tissue 
formation. Biomaterials and scaffolding may be used to deliver satellite cells to the soft palate 
muscles for improved regeneration. Both scaffolding and surface topography have been 
suggested to improve muscle fiber organization and alignment after cleft palate repair. To reduce 
fibrosis, signaling molecules such as decorin and nitric oxide could be used to down-regulate the 
activity of TGF- 1, though their roles in muscle regeneration needs to be further investigated 
before clinical use.  
As one of the most common birth defects, cleft palate and lip has been studied 
extensively. Genes, growth factors, and ECM involvement with both normal and pathological 
palatogenesis have been studied in various animal models. Numerous syndromes involving 
orofacial clefting have been identified. Previous knowledge about orofacial clefting has led to 
better surgical outcomes and improved treatments. However, because 3D printing and 
bioengineering are recent developments, more research is needed before they could be used as 
ways to repair orofacial clefting. As 3D printing and bioengineering technology matures, clinical 
trials might become available in humans, an exciting new direction toward not only palatal 
reconstruction, but regenerative medicine in general.  
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